This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Innovent Biologics (Suzhou) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
0
Company Filing History:
Years Active: 2026
Title: Kaijie He and His Patent Work in Biopharmaceutical Innovation.
Introduction
Kaijie He is an inventor based in Suzhou, China, whose patent work is associated with biopharmaceutical research. His listed patent concerns an interleukin-2 mutant and a fusion protein derived from it.
Latest Patents
He is associated with 1 patent: “Interleukin-2 Mutant and Fusion Protein Thereof.” The patent title indicates work involving a modified form of interleukin-2 and a related fusion protein.
Career Highlights
He is associated with Innovent Biologics (Suzhou) Co., Ltd., a biopharmaceutical company. His listed patent reflects a contribution to research involving therapeutic proteins.
Collaborations
Fenggen Fu and Weiwei Wu are listed as He’s coworkers. Their names are associated with his professional context, though the supplied information does not specify their roles in the patent.
Conclusion
Kaijie He’s recorded patent activity connects his work in Suzhou with biopharmaceutical innovation, particularly research on an interleukin-2 mutant and its fusion protein.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile